Remdesivir Use in the Setting of Severe Renal Impairment: A Theoretical Concern or Real Risk?
Natasha N. Pettit(University of Chicago), Kathleen M. Mullane(Karolinska University Hospital), Cynthia T. Nguyen(University of Chicago), Alison Lew(University of Chicago), Renslow Sherer(University of Chicago), Aniruddha Hazra(Howard Brown Health Center), Jennifer Pisano(University of Chicago)
Cited by 67
Related Papers
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
|New England Journal of Medicine|2017|1.2k
Mpox in people with advanced HIV infection: a global case series
|The Lancet|2023|482
Human monkeypox virus infection in women and non-binary individuals during the 2022 outbreaks: a global case series
|The Lancet|2022|149
Mpox in people with past infection or a complete vaccination course: a global case series
|The Lancet Infectious Diseases|2023|141